Pathway-specific differences between tumor cell lines and normal and tumor tissue cells
2006

Differences in Pathway Usage Between Tumor Cell Lines and Normal/Tumor Tissue Cells

Sample size: 35 publication Evidence: moderate

Author Information

Author(s): Ertel Adam, Verghese Arun, Byers Stephen W, Ochs Michael, Tozeren Aydin

Primary Institution: Drexel University

Hypothesis

The study aims to identify significant alterations in pathway usage in cell lines compared to normal and tumor tissue.

Conclusion

The study found that significantly altered genes in tumors compared to normal tissue were largely tissue-specific, while cell lines showed a large number of upregulated genes common across multiple tissue types.

Supporting Evidence

  • Cell lines showed significant upregulation in pathways related to ATP synthesis, cell cycle, and oxidative phosphorylation compared to tumor and normal tissues.
  • Only a fraction of significantly altered genes in tumor-to-normal comparisons had similar expressions in cancer cell lines and tumor cells.
  • Pathway-specific gene expression differences were consistent across multiple tissue types.

Takeaway

Researchers looked at how cancer cell lines behave differently from actual tumors and normal tissues, finding that cell lines often show different gene activity.

Methodology

The study used pathway-specific enrichment analysis of publicly accessible microarray data to quantify gene expression differences between cell lines, tumor, and normal tissue cells for six different tissue types.

Limitations

The study's findings may not fully represent in vivo conditions due to differences in the cell culture environment.

Participant Demographics

The study analyzed data from various tissue types including breast, CNS, colon, prostate, ovary, and renal tissues.

Digital Object Identifier (DOI)

10.1186/1476-4598-5-55

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication